This research was supported by Biomedical Research Council (BMRC 09/1/22/19/612) of A*STAR and Academic Research Fund (ARC21/08) of Ministry of Education in Singapore.
Orally Active Peptidic Bradykinin B1 Receptor Antagonists Engineered from a Cyclotide Scaffold for Inflammatory Pain Treatment†
Article first published online: 24 APR 2012
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Angewandte Chemie International Edition
Volume 51, Issue 23, pages 5620–5624, June 4, 2012
How to Cite
Wong, C. T. T., Rowlands, D. K., Wong, C.-H., Lo, T. W. C., Nguyen, G. K. T., Li, H.-Y. and Tam, J. P. (2012), Orally Active Peptidic Bradykinin B1 Receptor Antagonists Engineered from a Cyclotide Scaffold for Inflammatory Pain Treatment. Angew. Chem. Int. Ed., 51: 5620–5624. doi: 10.1002/anie.201200984
- Issue published online: 30 MAY 2012
- Article first published online: 24 APR 2012
- Manuscript Received: 6 FEB 2012
- Ministry of Education
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.